Back to Trades
Sell4
MADRIGAL PHARMACEUTICALS, INC.
MDGL
Total Value
$8.9M
Net $718.3K sold
Sales
$718.3K
1 transaction
Company Information
- Company Name
- MADRIGAL PHARMACEUTICALS, INC.
- Ticker Symbol
- MDGL
- CIK
- 0001157601
Insider Information
- Role
- President and CEO, Director
- Location
- WEST CONSHOHOCKEN, PA
DirectorOfficer
Filing Details
- Filing Date
- Mar 6, 2026
- Transaction Date
- Mar 4, 2026
- Accession Number
- 0001628280-26-015769
- Form Type
- 4
- Net Trading Amount
- -$718.3K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Common Stock | 14,995 | — | Grant/Award | — |
| Mar 6, 2026 | Common Stock | 1,663 | $431.94 | Sale | $718.3K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Mar 4, 2026 | Derivative | 18,743 | $434.80 | Grant/Award | $8.1M |
Footnotes
- (F1)Represents a grant of restricted stock units, which vest as to 25% of the shares on each of March 4, 2027, March 4, 2028, March 4, 2029 and March 4, 2030, provided the Reporting Person continues in service with the Issuer on each such date.
- (F2)This sale represents the number of shares sold by the Issuer on behalf of the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was automatic and not at the discretion of the Reporting Person.
- (F3)The option vests as to 25% of the shares on the first anniversary of the date of grant (March 4, 2027) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three-month period, provided the Reporting Person continues in service with the Issuer on each such date.